Posted by The latest transvaginal mesh lawsuit updates are primarily focused on the manufacturer Boston Scientific. While the company has settled most cases, there are still thousands of other claims pending in state and federal courts. In July of this year, a West Virginia jury awarded $3.6 million to a woman who suffered complications after receiving an Avaulta Plus implant. Although the company has settled several cases, the litigation remains active.
The companies that manufacture and distribute transvaginal mesh are negligent, and many women are pursuing legal action against them.
It is believed that the manufacturers are attempting to hide any problems with their products by passing the blame onto poor surgical techniques. It is expected that the debates surrounding the safety of vaginal mesh implants will continue for some time. Earlier this year, the UK government issued a series of guidelines that have been heavily criticized.
A recent settlement in the United States reportedly reached $168.7 million with Coloplast. The agreement amounts to $40k per claimant. While the FDA has not yet determined whether there is any danger associated with transvaginal mesh, several companies have reached settlements with patients for millions of dollars. Some women are winning multimillion-dollar verdicts from the manufacturers. Mary McGinnis and her husband won $68 million in 2018. Patricia Mesigian, a woman who suffered complications from the implant, has won more than 80 million.
A retrial of the first transvaginal mesh lawsuit will be held in September.
Judge Goodwin’s recommendation to settle the case is not binding on the companies. Ethicon, Boston Scientific, and C.R. Bard are all denying their products are defective. Nevertheless, the growing pressure on these companies may make them reconsider their stance. For more information about this trial, visit Carey Danis & Lowe’s website.
A major settlement with Coloplast and more than 25,000 other claims have been reached, but the settlement does not mean that the manufacturer is responsible for the problems caused by the transvaginal mesh. The company has a legal duty to ensure that its products are safe for its customers and have been proven to cause injuries. However, they hid these risks and made them difficult to remove. The companies evaded liability by providing inaccurate information about the safety of their products.
In the United States, there have been over 100,000 cases filed against the manufacturers of transvaginal mesh.
More than a million of these cases have been consolidated in West Virginia’s multidistrict litigation (MDL) courts. In Georgia, an MDL of bladder sling lawsuit has been filed against Mentor, and a second MDL for the mesh has been filed in California. More than a dozen lawsuits are pending against the manufacturer of the pelvic mesh.
There have been other lawsuits against Transvaginal mesh manufacturers. The first one was settled in New Jersey for $11.1 million. This represents a substantial amount of compensation for each claimant. The second case was settled for more than $40 million. These settlements involve many different types of injuries and include loss of income. Whether you have a problem or have a medical condition, you should contact a lawyer as soon as possible.
The first transvaginal mesh lawsuit was filed in West Virginia by Susan McFarland. The woman’s pelvic mesh surgeon, Dr. William Gratz, failed to provide the proper information to the patient. In the end, she had to undergo a second surgery to have the implant removed. As a result of the complications, the manufacturer lost the case. Fortunately, the trial is ongoing.
The second transvaginal mesh lawsuit in West Virginia involved a woman who had her Obtryx implanted in 2008.
She is now claiming permanent nerve damage and pain in her pelvic area. The court awarded her $120 million. In March 2017, a jury in Philadelphia ordered J& J and its subsidiary, Ethicon, to pay a total of $117 million in compensation. The companies were found to have misrepresented the safety of their surgical mesh products.
The third lawsuit concerns the FDA’s approval of a transvaginal mesh treatment. The FDA ordered the manufacturers to stop selling their products after receiving too many complaints. While the FDA hasn’t determined whether mesh was dangerous, it has recommended that it be studied and tested for risks before its use. The plaintiffs are now seeking compensation for these medical problems. While transvaginal mesh is a surgical procedure, the device can be attached to the vaginal wall.